- Home
- KROS vs VEL Comparison
KROS vs VEL Comparison
Compare KROS & VEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KROS
- VEL
- Stock Information
- Founded
- KROS 2015
- VEL 2004
- Country
- KROS United States
- VEL United States
- Employees
- KROS N/A
- VEL N/A
- Industry
- KROS Biotechnology: Pharmaceutical Preparations
- VEL Finance: Consumer Services
- Sector
- KROS Health Care
- VEL Finance
- Exchange
- KROS Nasdaq
- VEL Nasdaq
- Market Cap
- KROS 565.0M
- VEL 602.1M
- IPO Year
- KROS 2020
- VEL 2020
- Fundamental
- Price
- KROS $15.17
- VEL $18.71
- Analyst Decision
- KROS Buy
- VEL Strong Buy
- Analyst Count
- KROS 14
- VEL 3
- Target Price
- KROS $20.56
- VEL $21.67
- AVG Volume (30 Days)
- KROS 1.1M
- VEL 63.4K
- Earning Date
- KROS 11-06-2025
- VEL 11-06-2025
- Dividend Yield
- KROS N/A
- VEL N/A
- EPS Growth
- KROS N/A
- VEL 26.95
- EPS
- KROS 0.47
- VEL 2.22
- Revenue
- KROS $232,844,000.00
- VEL $195,592,000.00
- Revenue This Year
- KROS $6,657.47
- VEL $3.99
- Revenue Next Year
- KROS N/A
- VEL $29.69
- P/E Ratio
- KROS $32.70
- VEL $8.45
- Revenue Growth
- KROS 85820.30
- VEL 44.29
- 52 Week Low
- KROS $9.12
- VEL $16.12
- 52 Week High
- KROS $72.37
- VEL $20.98
- Technical
- Relative Strength Index (RSI)
- KROS 49.12
- VEL 58.60
- Support Level
- KROS $14.86
- VEL $17.74
- Resistance Level
- KROS $15.30
- VEL $18.73
- Average True Range (ATR)
- KROS 0.58
- VEL 0.35
- MACD
- KROS 0.02
- VEL 0.06
- Stochastic Oscillator
- KROS 72.85
- VEL 82.91
About KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
About VEL Velocity Financial Inc.
Velocity Financial Inc is a United States-based real estate finance company. The company originates and manages investor loans secured by residential rental and small commercial properties. The company earns revenue in the form of interest income. It operates in New York, California, Florida, New Jersey, and other states.